Questions and Concerns About HPV Vaccine: A Communication Experiment
Questions and Concerns About HPV Vaccine: A Communication Experiment
复制标题
关于人乳头瘤病毒（HPV）疫苗的疑问与担忧：一项沟通实验
DOI：
10.1542/peds.2018-1872
复制
发表时间：
2019-02-01
期刊：
影响因子：
8
通讯作者：
Brewer, Noel T.
中科院分区：
文献类型：
--
作者：
Shah, Parth D.;Calo, William A.;Brewer, Noel T.
目标：我们寻求针对家长对人乳头瘤病毒 (HPV) 疫苗的疑问和担忧找到有效的应对措施。方法：2017-2018 年，我们对 1196 名 9 至 17 岁儿童的美国父母进行了全国抽样调查。我们录制了儿科医生的简短视频，内容涉及 7 个通常引起问题或担忧的 HPV 疫苗接种主题（例如，建议年龄）。我们将家长随机分配到其中 1 个消息主题；然后，家长以随机顺序观看了有关该主题的 4 个视频并评估了其中的信息。结果：当父母接触到有关 HPV 疫苗知识缺乏的信息（b = 0.13；P = .01）、包含癌症预防信息的信息（b = 0.11；P < .001）、需要更高阅读水平的信息（b = 0.02；P = .01）和较长的信息（b = 0.03；P < .001）时，他们对 HPV 疫苗更有信心。当父母接触到表达紧迫性的信息时，他们对 HPV 疫苗的信心降低 (b = -0.06；P = .005)。使用 HPV 疫苗动机作为结果进行的分析揭示了相同的结果模式。结论：我们提供经过研究测试的信息，提供者可以使用这些信息来解决父母的 HPV 疫苗接种问题和对 7 个常见主题的担忧。提高信息有效性的重要原则是包含有关疫苗接种益处（包括预防癌症）的信息，并在解决家长的问题或疑虑时避免表达疫苗接种的紧迫性。此外，提供者可能需要准备好与表达对 HPV 疫苗担忧的家长进行更长时间的对话，尤其是在安全性和副作用方面。
OBJECTIVES: We sought to identify effective responses to parents' questions and concerns about human papillomavirus (HPV) vaccine. METHODS: In 2017-2018, we surveyed a national sample of 1196 US parents of children aged 9 to 17 years. We recorded brief videos of a pediatrician providing messages that addressed 7 HPV vaccination topics that commonly elicit questions or concerns (eg, recommended age). We randomly assigned parents to 1 of the message topics; parents then viewed 4 videos on that topic in random order and evaluated the messages. RESULTS: Parents were more confident in HPV vaccine when they were exposed to messages that addressed lack of knowledge about HPV vaccine (b = 0.13; P = .01), messages that included information about cancer prevention (b = 0.11; P < .001), messages that required a higher reading level (b = 0.02; P = .01), and messages that were longer (b = 0.03; P < .001). Parents were less confident in HPV vaccine when exposed to messages in which urgency was expressed (b = -0.06; P = .005). Analyses conducted by using HPV vaccine motivation as an outcome revealed the same pattern of findings. CONCLUSIONS: We provide research-tested messages that providers can use to address parents' HPV vaccination questions and concerns about 7 common topics. Important principles for increasing message effectiveness are to include information on the benefits of vaccination (including cancer prevention) and avoid expressing urgency to vaccinate when addressing parents' questions or concerns. Additionally, providers may need to be prepared to have longer conversations with parents who express concerns about HPV vaccine, especially regarding safety and side effects.